Viswanadhan Krishnan
- SEC CIK
- 0001999913
In the past year, 2 open-market sale filings worth $185.0K and no purchases.
Current role at each company
- AGIO Agios Pharmaceuticals, Inc.Chief Strategy and Operationsas of Jun 23, 2026
- CRGX CARGO Therapeutics, Inc.Directoras of Aug 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $185.0K
- 2 filings
- Net
- −$185.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Viswanadhan Krishnan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AGIO Agios Pharmaceuticals, Inc.
Chief Strategy and Operations2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Viswanadhan KrishnanChief Corp Dev & Strategy | SSale | −2.96K | $34.71 | −$102.7K | −22.3%10.3K after | 10b5-1 |
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Viswanadhan KrishnanChief Corp Dev & Strategy | SSale | −2.96K | $27.80 | −$82.3K | −36.5%5.14K after | 10b5-1 |